Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis

@article{Musso2014AssociationON,
  title={Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis},
  author={Giovanni Musso and R Gambino and James H. Tabibian and Mattias Ekstedt and Stergios Kechagias and Masahide Hamaguchi and Rolf Hultcrantz and Hannes Hagstr{\"o}m and Seung Kew Yoon and Phunchai Charatcharoenwitthaya and Jacob George and Francisco Barrera and Svanhildur Hafliðad{\'o}ttir and Einar S. Bj{\"o}rnsson and Matthew James Armstrong and Laurence Joseph Hopkins and Xin Gao and Sven M Francque and An Verrijken and Yusuf Yılmaz and Keith D. Lindor and Michael R. Charlton and Robin Haring and Markus M. Lerch and Rainer Rettig and Henry V{\"o}lzke and Seungho Ryu and Guolin Li and Linda L. Wong and Mariana Verdelho Machado and Helena Cortez‐Pinto and Kohichiroh Yasui and Maurizio Cassader},
  journal={PLoS Medicine},
  year={2014},
  volume={11}
}
In a systematic review and meta-analysis, Giovanni Musso and colleagues examine the association between non-alcoholic fatty liver disease and chronic kidney disease. Please see later in the article for the Editors' Summary 

Figures and Tables from this paper

Review article: non‐alcoholic fatty liver disease and cardiovascular diseases: associations and treatment considerations
TLDR
There are increasing data on the association between non‐alcoholic fatty liver disease (NAFLD) and cardiovascular diseases (CVD), and the need for further research is needed to establish a causative mechanism.
Chronic kidney disease is independently associated with increased mortality in patients with nonalcoholic fatty liver disease
TLDR
The aim was to assess the association between different stages of chronic kidney disease and mortality in patients with nonalcoholic fatty liver disease.
Optimizing patients with non-alcoholic fatty liver disease pre-transplant
TLDR
A large number of patients diagnosed with non-alcoholic fatty liver disease in Western countries with a history of liver disease or cirrhosis are likely to have had at least one episode of alcohol-related liver disease.
Beyond the liver in patients with non-alcoholic fatty liver disease (NAFLD)-cause for concern?
TLDR
The prevalence of NAFLD is approximately 30%, irrespective of ethnicity, and parallels the exponential rise of the obesity and diabetes epidemics.
Obesity is an independent risk factor for non‐alcoholic fatty liver disease: evidence from a meta‐analysis of 21 cohort studies
TLDR
A meta‐analysis of cohort studies was performed to elucidate the NAFLD risk associated with obesity and found no clear relationship between obesity and nonalcoholic fatty liver disease.
Metabolic associated fatty liver disease is a risk factor for chronic kidney disease
TLDR
To clarify the relationship between metabolic dysfunction‐associated fatty liver disease (MAFLD) and chronic kidney disease (CKD), a large number of patients with MFLD and CKD are diagnosed with at least some form of kidney disease.
Does Diagnosing Fatty Liver and Chronic Kidney Disease Do More Good Than Harm?
TLDR
In a linked Perspective, Druin Burch examines the usefulness of screening for risk factors of cardiovascular disease and concludes that it is likely that screening for these factors is more important than cholesterol levels.
Relations of liver fat with prevalent and incident chronic kidney disease in the Framingham Heart Study: A secondary analysis
TLDR
This work examined the association between liver fat and prevalent and incident CKD in the Framingham Heart Study (FHS) and found an association between non‐alcoholic fatty liver disease and chronic kidney disease.
Occurrence over time and regression of nonalcoholic fatty liver disease in type 2 diabetes
This analysis was aimed to assess the incidence, regression, and correlated factors of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes, which are poorly known.
Short‐term weight loss decreased the risk of chronic kidney disease in men with incident nonalcoholic fatty liver disease
The study aimed to examine the association of obesity and chronic kidney disease (CKD) after nonalcoholic fatty liver disease (NAFLD) occurrence.
...
...

References

SHOWING 1-10 OF 122 REFERENCES
Impact of non‐alcoholic fatty liver disease on microalbuminuria in patients with prediabetes and diabetes
TLDR
This study investigated the association of NAFLD with microalbuminuria among patients with prediabetes and diabetes.
Increased prevalence of chronic kidney disease in patients with Type 1 diabetes and non‐alcoholic fatty liver
Diabet. Med. 29, 220–226 (2012)
The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the
Impaired renal function in morbid obese patients with nonalcoholic fatty liver disease
TLDR
It is hypothesize that more severe liver disease, namely nonalcoholic steatohepatitis (NASH), is related with further renal impairment, and it is aimed to evaluate if changes in renal function were present in morbid obese patients with NAFLD.
Can Non-alcoholic fatty liver disease (NAFLD) as a marker for microalbuminuria in prediabetes group?
TLDR
Microalbuminuria levels were found to be significantly higher in Prediabetes patients with non alcoholic fatty liver disease than prediabetes alone.
Non-alcoholic Fatty Liver Disease and Chronic Kidney Disease in Koreans Aged 50 Years or Older
TLDR
NAFLD diagnosed by ultrasonography was significantly associated with CKD in Koreans aged 50 years or older, and this relationship remained significant after classification according to the presence of hypertension or diabetes mellitus.
Implications of worse renal dysfunction and medical comorbidities in patients with NASH undergoing liver transplant evaluation: impact on MELD and more
TLDR
Patients with NASH undergoing liver transplant evaluation are evaluated for renal dysfunction, medical comorbidities, and the impact on MELD and more.
Plasma fetuin‐A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease
TLDR
The relationship of circulating fetuin‐A level with markers of endothelial dysfunction and presence of carotid atherosclerosis in subjects with NAFLD is investigated.
Association between Nonalcoholic Liver Disease and Chronic Kidney Disease: An Ultrasound Analysis from NHANES 1988–1994
TLDR
After adjusting for features of metabolic syndrome, ultrasound-diagnosed NAFLD is not associated with prevalent CKD among US adults and Aggressive public health efforts are needed to prevent and treat metabolic syndrome.
...
...